Fairview Capital Investment Management, LLC Abbott Laboratories Transaction History

Fairview Capital Investment Management, LLC

$1.67 Billion
Q3 2024

A detailed history of Fairview Capital Investment Management, LLC transactions in Abbott Laboratories stock. As of the latest transaction made, Fairview Capital Investment Management, LLC holds 4,786 shares of ABT stock, worth $549,241. This represents 0.03% of its overall portfolio holdings.

Number of Shares

4,786

Previous 5,007 4.41%

Holding current value

$549,241

Previous $520,000 4.81%

% of portfolio

0.03%

Previous 0.03%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$100.07 - $118.13 $22,115 - $26,106	-221 Reduced 4.41%	4,786 $545,000
Q2 2024 Aug 14, 2024	SELL	$100.73 - $112.44 $897,806 - $1 Million	-8,913 Reduced 64.03%	5,007 $520,000
Q1 2024 May 15, 2024	SELL	$109.52 - $120.96 $5,476 - $6,048	-50 Reduced 0.36%	13,920 $1.58 Million
Q4 2023 Feb 13, 2024	SELL	$90.19 - $110.4 $5,050 - $6,182	-56 Reduced 0.4%	13,970 $1.54 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $7,167 - $8,436	-74 Reduced 0.52%	14,026 $1.42 Million
Q4 2022 Feb 10, 2023	BUY	$95.06 - $111.52 $1,330 - $1,561	14 Added 0.1%	14,100 $1.55 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $21,383 - $24,758	221 Added 1.59%	14,086 $1.36 Million
Q2 2022 Aug 12, 2022	BUY	$102.07 - $123.37 $898,215 - $1.09 Million	8,800 Added 173.74%	13,865 $1.51 Million
Q1 2022 May 16, 2022	SELL	$114.02 - $139.04 $17,103 - $20,856	-150 Reduced 2.88%	5,065 $599,000
Q3 2021 Nov 15, 2021	SELL	$116.66 - $129.06 $46,664 - $51,624	-400 Reduced 7.12%	5,215 $616,000
Q2 2021 Aug 16, 2021	SELL	$105.79 - $124.53 $21,898 - $25,777	-207 Reduced 3.56%	5,615 $650,000
Q3 2020 Nov 16, 2020	BUY	$91.64 - $111.29 $2,199 - $2,670	24 Added 0.41%	5,822 $633,000
Q1 2020 May 13, 2020	SELL	$62.82 - $91.86 $22,426 - $32,794	-357 Reduced 5.8%	5,798 $457,000
Q1 2019 May 14, 2019	SELL	$66.22 - $80.06 $860 - $1,040	-13 Reduced 0.21%	6,155 $492,000
Q4 2018 Feb 12, 2019	BUY	$65.56 - $74.27 $9,899 - $11,214	151 Added 2.51%	6,168 $446,000
Q3 2018 Nov 09, 2018	BUY	$60.81 - $73.36 $16,601 - $20,027	273 Added 4.75%	6,017 $441,000
Q2 2018 Aug 14, 2018	BUY	$57.57 - $63.54 $17,904 - $19,760	311 Added 5.72%	5,744 $350,000
Q3 2017 Nov 13, 2017	BUY	$48.06 - $53.64 $261,109 - $291,426	5,433	5,433 $290,000

Others Institutions Holding ABT

# of Institutions

3,186

Shares Held

1.3B

Call Options Held

8.74M

Put Options Held

8.08M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $201B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fairview Capital Investment Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fairview Capital Investment Management, LLC with notifications on news.

Account

Fairview Capital Investment Management, LLC Abbott Laboratories Transaction History